Protocol No
NEURO-EMD-HDA-SWITCH
Phase
N/A
Summary
This study is being done to better understand the effectiveness of switching to Mavenclad (cladribine) in patients who have RMS, RRMS and aSPMS.
Description
Cladribine Tablets in MS with High Disease Activity or Disease Breakthrough
Participating Institutions
Froedtert Hospital
Status
OPEN TO ACCRUAL